Abstract:Antibiotic selection for the maintenance of expression plasmids is discouraged in the production of recombinant proteins for pharmaceutical or other human uses due to the risks of antibiotic residue contamination of the final products and the release of DNA encoding antibiotic resistance into the environment. We describe the construction of expression plasmids that are instead maintained by complementation of the lgt gene encoding a (pro)lipoprotein glyceryl transferase essential for the biosynthesis of bacterial lipoprotein. Mutations in lgt are lethal in Escherichia coli and other Gram-negative organisms. The lgt gene was deleted from E. coli and complemented by the Vibrio cholerae-derived gene provided in trans on a temperature-sensitive plasmid, allowing cells to grow at 30°C but not at 37°C. A temperature-insensitive expression vector carrying the V. cholerae-derived lgt gene was constructed, whereby transformants were selected by growth at 39°C. The vector was successfully used to express two recombinant proteins, one soluble and one forming insoluble inclusion bodies. Reciprocal construction was done by deleting the lgt gene from V. cholerae and complementing the lesion with the corresponding gene from E. coli The resulting strain was used to produce the secreted recombinant cholera toxin B subunit (CTB) protein, a component of licensed as well as newly developed oral cholera vaccines. Overall, the lgt system described here confers extreme stability on expression plasmids, and this strategy can be easily transferred to other Gram-negative species using the E. coli-derived lgt gene for complementation.IMPORTANCE Many recombinant proteins are produced in bacteria from genes carried on autonomously replicating DNA elements called plasmids. These plasmids are usually inherently unstable and rapidly lost. This can be prevented by using genes encoding antibiotic resistance. Plasmids are thus maintained by allowing only plasmid-containing cells to survive when the bacteria are grown in medium supplemented with antibiotics. In the described antibiotic-free system for the production of recombinant proteins, an essential gene is deleted from the bacterial chromosome and instead provided on a plasmid. The loss of the plasmid becomes lethal for the bacteria. Such plasmids can be used for the expression of recombinant proteins. This broadly applicable system removes the need for antibiotics in recombinant protein production, thereby contributing to reducing the spread of genes encoding antibiotic resistance, reducing the release of antibiotics into the environment, and freeing the final products (often used in pharmaceuticals) from contamination with potentially harmful antibiotic residues.

Overexpression of the phage lambda lysozyme cloned in Escherichia coli: use of a degenerative mixture of synthetic ribosome binding sites and increase of the protein stability in vivo.

Overexpression of Rhizomucor miehei Lipase and Activity Assay

Improved, two-stage protein expression and purification via autoinduction of both autolysis and auto DNA/RNA hydrolysis conferred by phage lysozyme and DNA/RNA endonuclease

[Construction and Verification of the Effectiveness of Pmbl: a Cloning Vector of Exported Proteins Encoding Genes].

Simultaneous Expression of Vitreoscilla Globin Gene and Lytic Genes of Phage Lambda in A Novel Recombinant Escherichia Coli Used for Production of Phb

An efficient expression and secretion system based on Bacillus subtilis phage phi 105 and its use for the production of B. cereus beta-lactamase I

Heterologous expression of Lactobacillus casei phospholipase A2 in Escherichia coli

Construction of recombinant lambda phages that carry the E. coli recB and recC genes.

Cloning and Heterologous Expression in E.coli of Phospholipase C Gene from Bacillus Cereus

[Expression of hemolytic phospholipase C from Pseudomonas aeruginosa in Escherichia coli].

Overexpression , Purification , and Characterization of Escherichia coli Bacteriophage PRDl DNA Polymerase

Heterologous expression and purification of the phage lysin-like bacteriocin LysL from Lactococcus lactis LAC460

Bacteriophage inspired growth-decoupled recombinant protein production in Escherichia coli.

Functional Analysis of E. Coli Class II Release Factor RF3 Mutants

Efficient Molecular Biological Manipulations with Improved Strategies Based on Novel Escherichia Coli Vectors.

High-Resolution View of Bacteriophage Lambda Gene Expression by Ribosome Profiling

Improved Escherichia coli Bactofection and Cytotoxicity by Heterologous Expression of Bacteriophage ΦX174 Lysis Gene E.

A Novel Nonantibiotic, lgt-Based Selection System for Stable Maintenance of Expression Vectors in Escherichia coli and Vibrio cholerae

Molecular Amplification and Purification of Thee. Colt Reccgene Product

Construction Of Recombinant Lambda-Phages That Carry The Escherichia-Coli Recb And Recc Genes

Simultaneous Expression of Glutaryl-7-aminocephalosporanic Acid Acylase Gene and Lysis Genes of Phage Λ in a Recombinant E. Coli